Allogeneic Human Cardiosphere-Derived Stem Cells

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
86	肺動脈性肺高血圧症	1

86. 肺動脈性肺高血圧症

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03145298 (ClinicalTrials.gov)	October 1, 2017	2/5/2017	ALlogeneic Cardiosphere-derived Stem Cells (CDCs) for Pulmonary Hypertension therApy	A Phase I Study of the Safety and Feasibility of Central Intravenous Delivery of Allogeneic Human Ca ...	Pulmonary Arterial Hypertension (PAH)	Biological: Allogeneic Human Cardiosphere-Derived Stem Cells;Biological: Placebo	Cedars-Sinai Medical Center	California Institute for Regenerative Medicine (CIRM)	Active, not recruiting	18 Years	75 Years	All	26	Phase 1	United States

First Previous1Next Last